Nalaganje...
The time-course of protection of the RTS,S vaccine against malaria infections and clinical disease
BACKGROUND: Recent publications have reported follow-up of the RTS,S/AS01 malaria vaccine candidate Phase III trials at 11 African sites for 32 months (or longer). This includes site- and time-specific estimates of incidence and efficacy against clinical disease with four different vaccination sched...
Shranjeno v:
| izdano v: | Malar J |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BioMed Central
2015
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4634589/ https://ncbi.nlm.nih.gov/pubmed/26537608 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0969-8 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|